棒丝氨酸的全合成研究 Ⅰ.从D-葡萄糖合成3-[(3′R,5′S)-7′-氧代-1′-氮杂-4′-氧杂双环[3.2.0]-庚-3′-基]-3-O-苄基-(2S,3S)-丝氨酸及其(3′R,5′R)-差向异构体

以D-葡萄糖为原料经侧链氨基酸合成,与β-内酰胺缩合,嗯唑烷环合和除保护基等反应合成了棒丝氨酸的O-苄基衍生物,3-[(3′R,5′S)-7′-氧代-1-氮杂-4-氧杂双环[3.2.0]-庚-3′-基]-3-O-苄基-(2S,3S)-丝氨酸(17)及其(3′R,5′R)差向异构体(18)。     

(1R,3S,4S)-2-苄氧羰基-2-氮杂双环[2.2.1]庚烷-3-羧酸的合成

以(R)-(+)-α-甲基苄胺为原料,依次经缩合,Diels-Alder反应,还原,Cbz-保护和水解反应,合成了抗丙肝新药HCV NS3/4A蛋白酶拟肽类抑制剂的重要中间体——(1R,3S,4S)-2-苄氧羰基-2-氮杂双环[2.2.1]庚烷-3-羧酸,总收率66%,其结构经1H NMR和ESI-MS确证。     

杂环光化学IV.1,2,4-三氮杂-双环[4.2.0]辛烷衍生物的光化学合成

通过1,3-二甲基-6-氮杂胸腺嘧啶与含极性取代基的烯类化合物的光环合加成反应,合成了1,2,4-三氮杂-2,4,6-三甲基-3,5-二氧-8-乙酰基-双环[4.2.0]辛烷的三个差异构体(6R,8S)-1a,(6S,8R)-2a和(6R,8R)-3a;1,2,4-三氮杂-2,4,6-三甲基-3,5-二氧-8-氰基-双环[4.2.0]辛烷的两个差相异构体(6S,8R)-2b和(6R,8R)-3b以及1,2,4-三氮杂-2,4,6-三甲基-3,5-二氧-8-羧甲酯基的两个差相异构体.讨论了该反应的区域选择性,以及产物的立体化学。     

杂环光化学 Ⅳ.1,2,4-三氮杂-双环[4.2.0]辛烷衍生物的光化学合成

通过1,3-二甲基-6-氮杂胸腺嘧啶与含极性取代基的烯类化合物的光环合加成反应,合成了1,2,4-三氮杂-2,4,6-三甲基-3,5-二氧-8-乙酰基一双环[4.2.0]辛烷的三个差向异构体(6R,8S)-1a,(6S,8R)-2a和(6R,8R)-3a;1,2,4-三氮杂-2,4,6-三甲基_3,5-二氧-8-氰基-双环[4.2.0]辛烷的两个差相异构体(6S,8R)-2b和(6R,8R)-3b以及1,2,4-三氮杂-2,4,6-三甲基-3,5-二氧-8-羧甲酯基的两个差相异构体.讨论了该反应的区域选择性,以及产物的立体化学.     

(6R,7R)-7-氨基-3-[2-(4-甲基-5-噻唑)乙烯基]-8-氧代-5-硫-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸的合成

以1-磺丁基-3-甲基咪唑硫酸氢盐离子液体(b)为反应介质,7-氨基头孢烷酸(7-ACA,2)为原料,与4-甲基-5-甲酰基噻唑经缩合反应制得(6R,7R)-7-氨基-3-[2-(4-甲基-5-噻唑)乙烯基]-8-氧代-5-硫-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸(7-ATCA,1),其结构经1H NMR,13C NMR和IR表征。考察了离子液体及其用量,原料摩尔比r[n(4-甲基-5-甲酰基噻唑)∶n(2)],反应温度和反应时间对1收率的影响。在最佳反应条件[b为反应介质,b用量为20 m L,r=1.3,于65℃反应5 h]下,1收率可达90%以上。     

顺式-4-氨基环戊-2-烯-1-羧酸的手性拆分

采用(±)-2-氮杂双环[2.2.1]庚-5-烯-3-酮开环酯化路线,以酒石酸为拆分试剂制得L-酒石酸(1S,4R) -4-氨基环戊-2-烯-1-羧酸甲酯(4),总收率45.5％,光学纯度99％.由4可合成制备帕拉米韦的中间体顺式-4-氨基环戊-2-烯-1-羧酸.     

合成(3R,4R)-3-[(1'R)-叔丁基二甲基硅氧乙基]-4-乙酰氧基-2-氮杂环丁酮的新方法

(3R,4R)-3-[(1'R)-叔丁基二甲基硅氧乙基]-4'-乙酰氧基-1-对甲氧基苯基-2-氮杂环丁酮依次经铋酸钠/浓硫酸体系氧化和亚硫酸氢钠还原,合成了培南类药物的重要中间体——(3R,4R)-3-[(1'R)-叔丁基二甲基硅氧乙基]-4-乙酰氧基-2-氮杂环丁酮(1),收率62%,纯度98%,其结构经1H NMR,IR和EI-MS表征。     

1,4-二硝基-2,3-二硝胺基哌嗪的合成

本文以乙二胺, 乙二醛和脲为原料, 通过Mannich反应, 合成出2,5,7,9-四氮杂双环[4.3.0]壬-8-酮盐酸盐(1); 化合物1 亚硝化给出2,5-二亚硝基-2,5,7,9-四氮杂双环[4.3.0]壬-8-酮(2); 硝化化合物2制得2,5,7,9-四硝基-2,5,7,9-四氮杂双环[4.3.0]壬-8-酮(3); 化合物3水解制得1,4-二硝基-2,3-二硝胺基哌嗪(4).     

1-(3-氨基丙基)-2,8,9-三氧杂-5-氮杂-1-硅杂双环[3,3,3]十一烷衍生物的合成及其抗肿瘤活性研究

通过1-(3-氨基丙基)-2,8,9-三氧杂-5-氮杂-1-硅杂双环[3,3,3]十一烷与酸反应或1-(3-氯丙基)-2,8,9-三氧杂-5-氮杂-1-硅杂双环[3,3,3]十一烷与胺反应,合成了14种1-(3-氨基丙基)-2,8,9-三氧杂-5-氮杂-1-硅杂双环[3,3,3]十一烷衍生物.体外细胞培养试验结果表明,某些1-(3-氨基丙基)-2,8,9-三氧杂-5-氮杂-1-硅杂双环[3,3,3]十一烷衍生物对艾氏腹水癌细胞具有较好的杀伤活性.     

分子内1,3-偶极环加成反应的研究 I.4-取代苯基(N-4-戊烯基)硝酮的热化学反应性能及其区域选择性

合成并研究了4-取代苯基(N-4-戊烯基)硝酮的热化学反应[取代基为OCH~3(1a),H(1b),Br(1c),NO~2(1d)].环加成反应活性顺序为NO~2>Br>H>OHC~3.反应具有区域选择性,加成物8-(4-取代苯基)-2-氧杂-1-氮杂双环[3.2.1]辛烷(2)和2-(4-取代苯基)-8-氧杂-1-氮杂双环[3.2.1]辛烷(3)的比约为2:1. 1,3-偶极硝酮(1a-1d)可部分转变为双键迁移产物(4a-4d).     

Vapour-liquid equilibrium measurements for binary mixtures of R32, R143a, R134a and R125 with a perfluoropolyether lubricant

In the present work, vapour-liquid equilibria of four binary systems refrigerant-lubricant oil have been investigated, CF₃CHF₂ (R125), CF₃CH₂F (R134a), CF₃CH₃ (R143a) and CH₂F₂ (R32) as refrigerants and a commercial perfluoropolyether (PFPE), Fluorolink D10H, as lubricant. Vapour-liquid equilibrium data, consisting of isothermal measurement of equilibrium pressure at a fixed composition, have been correlated with an extended Flory-Huggins equation and the corresponding parameters have been determined. Good agreement has been found between experimental data and the model predictions.     

Convenient synthesis of （2S,3R,4R,5S,6R）-2-（3-（4-ethylbenzyl）-4- chlorophenyl）-6-（hydroxymethyl）-tetrahydro- 2H-pyran-3,4,5-triol

A convenient approach for the preparation of （2S,3R,4R,5S,6R）-2-（3-（4-ethylbenzyl）-4-chlorophenyl）-6-（hydroxymethyl）- tetrahydro-2H-pyran-3,4,5-triol I is developed. The target compound via four steps is synthesized from 4-bromo-2-（bromomethyl）- 1-chlorobenzene and the isomers of undesired ortho-products were avoided during the preparation.     

La0.5R0.5Ba2Cu3O7,Pr0.5R0.5Ba2Cu3O7以及RBa2Cu3o7（R=稀土）的键共价性计

使用复杂晶体化学键理论计算了Ｌａ０．５Ｒ０．５Ｂａ２Ｃｕ３Ｏ７（Ｒ＝Ｐｒ,Ｎｄ,Ｓｍ,Ｅｕ,Ｇｄ,Ｄｙ,Ｙ,Ｈｏ,Ｅｒ,Ｔｍ,Ｙｂ,Ｌｕ）（Ｌａ－Ｒ１２３）,Ｐｒ０．５Ｒ０．５Ｂａ２Ｃｕ３Ｏ７（Ｒ＝Ｌａ,Ｎｄ,Ｓｍ,Ｅｕ,Ｇｄ,Ｄｙ,Ｈｏ,Ｙ,Ｅｒ,Ｔｍ,Ｙｂ,Ｌｕ）（Ｐｒ－Ｒ１２３）以及ＲＢａ２Ｃｕ３Ｏ７（Ｒ＝Ｌａ,Ｐｒ,Ｎｄ,Ｓｍ,Ｅｕ,Ｇｄ,Ｄｙ,Ｈｏ,Ｙ,Ｅｒ,Ｔｍ）（Ｒ１２３）中Ｃｕ－Ｏ键的键共价性,结果表明Ｐｒ－Ｒ１２３,Ｌａ－Ｒ１２３,以及Ｒ１２３都应具有超导性,而实验结果是Ｌａ０．５Ｐｒ０．５Ｂａ２Ｃｕ０７,Ｒ０．５,Ｐｒ０．５Ｂａ２Ｃｕ３Ｏ７（Ｒ＝Ｌａ,Ｎｄ,Ｓｍ,Ｅｕ,Ｇｄ）无超导性,产生这种矛盾的原因尚不明确,需要做进一步的研究。     

New method in synthesizing an optical active intermediate for (R,R)-formoterol

(R)-1-(4-Methoxyphenyl)propan-2-amine 2a,an optical active intermediate for (R,R)-formoterol,was synthesized from D- alanine in 65% overall yield by using a simple route,which contained protecting amino group,cyclization,coupling with Grignard reagent,reduction and deprotection.     

A Convenient Method for Synthesis of Novel Cyclic Ethers (1R,2R,3R,5S,7S,9R,12R)-3-(t-Butyldimethylsilyl)oxy-7-methoxymethyl-oxy-2,10-dimethyl-12-oxatricyclo [7.2.1.0~(5,12)] dodecane

Coloradocin, a novel macrolide antibiotic from cultures of Actinoplanes coloradoensis1exhibits activity against pathogenic anaerobic and microaerophilic species2. Because itslow toxicity and substantial oral activity3, , as well as its unusual structure5, several 4research groups initiated approaches towards the synthesis of coloradocin6, whichculminated in the synthesis of 18-deoxynargenicin A1 by Kallmerten et al.7. …     

（R）—N—乙酰四氢噻唑—2—硫酮—4—羧酸与醇的反应

（Ｒ）－Ｎ－乙酰四氢噻唑－２－硫酮－４－羧酸与醇反应，在ＳＯＣｌ２存在下得到乙酸酯及四氢噻唑－２－硫酮－４－羧酸酯；在碳酸钾存在下得到乙酸酯及四氢噻唑－２－硫酮－４－羧酸；在二环己基碳二亚胺（ＤＣＣ）存在下得到缩水产物Ｎ－乙酰四氢噻唑－２－硫酮－４－羧酸酯。     

Convergent synthesis of (2R,3R,8R,9R)-N-Boc-ADDA

The convergent synthesis of N-Boc-(2R,3R,8R,9R,4E,6E)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldecadenoic acid (enantio-N-Boc-ADDA) is reported. Our flexible approach takes advantage of highly efficient non-aldol aldol and cross-metathesis methodologies.     

ASYMMETRIC SYNTHESIS OF THE DERIVATIVES OF (+)-1R,3R(3S), 5S-2,4,3-DIAZAPHOSPHABICYCLO [3.2.1] OCTANE

A new series of dextrorotatory derivatives of 1R,3RS,5S-1,8,8-trimethyl-2,4,3-diazaphosphabicyclo [3.2.1] octane with a newly formed chiral phosphorus atom has been prepared by an asymmetric reaction of (+)-cis-1R,3S-1,2,2-trimethyl-1,3-cyclopentadiamine with some thiophosphoryl dichlorides. The optically active products consisted of two unequal amounts of diastereomers,(1R, 3R, 5S) isomers and(1R, 3S, 5S) isomers. Two regioselective reactions took place when phenoxy thiophosphoryl dichloride and N,N-dialkylamino thiophosphoryl dichlorides were chosen as the reagents for the reaction. The content of (1R, 3R, 5S) isomers in the product was over 90% for the former and there were only (1R, 3S, 5S) isomers obtained for the latter.     

Screening of allergic components mediated by H1R in homoharringtonine injection through H1R/CMC‐HPLC/MS

It has been reported that the histamine H₁ receptor (H₁R) gene is up‐regulated in patients with allergic rhinitis and H₁R expression level strongly correlates with the severity of allergy symptoms. Drugs for therapy should avoid allergy symptoms, especially for patients with over‐expressed H₁R. Therefore, screening of the components which could induce H₁R activation is urgently needed for drug safety evaluation. Homoharringtonine injection is a preparation for acute nonlymphocytic leukemia, which is approved by China Food and Drug Administration (CFDA) and US Food and Drug Administration. However, severely adverse reactions often occur with intravenous injection of the preparation. In present study, an H₁R/CMC model was applied for capturing membrane retained components which could induce H₁R activation. Retention components were enriched and analyzed by H₁R/CMC‐HPLC/MS. Homoharringtonine was recognized, separated and identified in homoharringtonine injection. Ca²⁺ flux assay and p‐IP3R expression founded that homoharringtonine retained by the H₁R/CMC model increased phosphorylation of IP3R and promoted cytosolic free Ca²⁺ elevation in a dose‐dependent manner which further verified the activity of homoharringtonine in activating the H₁R. In conclusion, homoharringtonine was screened and identified as a potential allergic factor. This provides an indication that a patient with over‐expressed H₁R should be aware of possible allergic reaction when applying homoharringtonine injection. Copyright © 2014 John Wiley & Sons, Ltd.     

(1R,2R)环己二胺Schiff碱双核配合物的合成与表征

合成了二(3-羧基水杨醛叉)缩(1R,2R)环己二胺Sch iff碱配体(H4DS)及其Cu(Ⅱ)和N i(Ⅱ)的同双核配合物.用元素分析,IR光谱和1H NMR对配合物的组成和结构进行了表征;用循环伏安法测定了配合物Cu2DS.2H2O的电化学性质.